0 XP   0   0   0

RespireRx Pharmaceuticals Inc
Buy or Sell?

I guess you are interested in RespireRx Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's start. I'm going to help you getting a better view of RespireRx Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is RespireRx Pharmaceuticals Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how RespireRx Pharmaceuticals Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value RespireRx Pharmaceuticals Inc. The closing price on 2022-09-23 was $0.0059 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Daily chart of RespireRx Pharmaceuticals Inc
RespireRx Pharmaceuticals Inc Daily Candlestick Chart

1.1. Profitability of RespireRx Pharmaceuticals Inc.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin
  • Measures how much profit a company generates for each dollar of revenue.
  • Above 10% is considered healthy depending on the industry.
  • A net profit margin of 25% means that $0,25 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of RespireRx Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--242.4%+242.4%
TTM--275.9%+275.9%
YOY--335.9%+335.9%
5Y--469.8%+469.8%
10Y--549.9%+549.9%
1.1.2. Return on Assets
  • Shows how profitable a company is in relation to its total assets.
  • Above 5% is considered healthy depending on the industry.
  • 5% return on assets means the company generated $0,05 for each $1 in assets.

Let's take a look of the Return on Assets trends of RespireRx Pharmaceuticals Inc:

  • The MRQ is -618.1%. Very bad. -2
  • The TTM is -532.3%. Very bad. -2
Trends
Current periodCompared to+/- 
MRQ-618.1%TTM-532.3%-85.7%
TTM-532.3%YOY-1,312.5%+780.2%
TTM-532.3%5Y-707.6%+175.3%
5Y-707.6%10Y-398.2%-309.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-618.1%-9.8%-608.3%
TTM-532.3%-8.8%-523.5%
YOY-1,312.5%-9.2%-1,303.3%
5Y-707.6%-11.6%-696.0%
10Y-398.2%-12.7%-385.5%
1.1.3. Return On Equity
  • Measures the profit in relation to shareholders equity (total assets - total liabilities).
  • Above 15%-20% is considered healthy depending on the industry
  • 10% return on equity means the company generated $0,1 for each $1 the owners (shareholders) invested.

Let's take a look of the Return On Equity trends of RespireRx Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y0.2%-0.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--11.9%+11.9%
TTM--11.2%+11.2%
YOY--10.6%+10.6%
5Y--13.7%+13.7%
10Y0.2%-14.5%+14.7%

1.2. Operating Efficiency of RespireRx Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin
  • Measures how much profit a company makes for each $1 of sales after paying variable costs (production costs, wages) but before taxes.
  • Above 15% is considered healthy depending on the industry
  • An operating margin of 20% means the company generated $0,2 for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of RespireRx Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--232.1%+232.1%
TTM--269.6%+269.6%
YOY--306.8%+306.8%
5Y--461.8%+461.8%
10Y--546.8%+546.8%
1.2.2. Operating Ratio
  • Measures how efficient the company is creating its products or services while keeping operating costs low.
  • Below 1 is considered healthy depending on the industry
  • An operation ratio of 0.5 means that the operating costs are $0,5 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of RespireRx Pharmaceuticals Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y2.754-2.754
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.321-3.321
TTM-3.662-3.662
YOY-3.692-3.692
5Y-5.743-5.743
10Y2.7546.919-4.165

1.3. Liquidity of RespireRx Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio
  • Measures if the company is able to pay off short-term debts (debts due within 1 year).
  • Above 1 is considered healthy depending on the industry.
  • A current ratio of 1.5 means the company has $1.5 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of RespireRx Pharmaceuticals Inc:

  • The MRQ is 0.007. Very bad. Indication that company has liquidity problems. -2
  • The TTM is 0.016. Very bad. Indication that company has liquidity problems. -2
Trends
Current periodCompared to+/- 
MRQ0.007TTM0.016-0.009
TTM0.016YOY0.012+0.004
TTM0.0165Y0.019-0.003
5Y0.01910Y0.012+0.006
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0075.318-5.311
TTM0.0166.219-6.203
YOY0.0126.366-6.354
5Y0.0196.760-6.741
10Y0.0126.520-6.508
1.3.2. Quick Ratio
  • Measures if the company is able to pay short-term debts (debts due within 1 year). But only uses the most liquid assets (cash, marketable securities and accounts retrievable).
  • Above 1 is considered healthy depending on the industry.
  • A quick ratio of 0,8 means the company can pay off $0,8 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of RespireRx Pharmaceuticals Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.107-4.107
TTM-4.994-4.994
YOY-5.257-5.257
5Y-5.338-5.338
10Y-5.050-5.050

1.4. Solvency of RespireRx Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt To Asset Ratio
  • Shows if the company is owned by creditors or shareholders.
  • Below 1 (100%) is considered healthy depending on the industry
  • A debt to asset ratio of 0.45 (45%) means that the company is financed with 45% credit and 55% is financed by it's owners (shareholders).

Let's take a look of the Debt To Asset Ratio trends of RespireRx Pharmaceuticals Inc:

  • The MRQ is 144.247. Very Bad. More debt than assets. -2
  • The TTM is 85.337. Very Bad. More debt than assets. -2
Trends
Current periodCompared to+/- 
MRQ144.247TTM85.337+58.910
TTM85.337YOY92.573-7.236
TTM85.3375Y70.215+15.122
5Y70.21510Y48.711+21.504
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ144.2470.269+143.978
TTM85.3370.267+85.070
YOY92.5730.296+92.277
5Y70.2150.362+69.853
10Y48.7110.398+48.313
1.4.2. Debt to Equity Ratio
  • Measures the total debt versus the total shareholders equity (total assets - total liabilities).
  • Below 2 is considered healthy depending on the industry.
  • A debt to equity ratio of 0.84 means that company has $0,84 debt for each $1 in equity.

Let's take a look of the Debt to Equity Ratio trends of RespireRx Pharmaceuticals Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y1.629-1.629
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.305-0.305
TTM-0.303-0.303
YOY-0.309-0.309
5Y-0.382-0.382
10Y1.6290.436+1.193

2. Market Valuation of RespireRx Pharmaceuticals Inc

2. Earnings
2.1. Price to Earnings Ratio
  • Compares the company's stock price to its earnings.
  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of 15 means the investor is paying $15 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of RespireRx Pharmaceuticals Inc:

  • The EOD is -0.180. Company is losing money. -2
  • The MRQ is -0.116. Company is losing money. -2
  • The TTM is -0.259. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-0.180MRQ-0.116-0.064
MRQ-0.116TTM-0.259+0.143
TTM-0.259YOY-0.223-0.036
TTM-0.2595Y-0.138-0.121
5Y-0.13810Y-0.078-0.060
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.180-2.088+1.908
MRQ-0.116-2.275+2.159
TTM-0.259-3.796+3.537
YOY-0.223-4.994+4.771
5Y-0.138-3.642+3.504
10Y-0.078-3.303+3.225
2.2. Price/Earnings-to-Growth Ratio

Let's take a look of the Price/Earnings-to-Growth Ratio trends of RespireRx Pharmaceuticals Inc:

  • The MRQ is 0.002. Very good. +2
  • The TTM is 0.003. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.002TTM0.003-0.001
TTM0.003YOY0.002+0.001
TTM0.0035Y0.002+0.001
5Y0.00210Y0.001+0.002
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0020.005-0.003
TTM0.0030.020-0.017
YOY0.0020.041-0.039
5Y0.0020.021-0.019
10Y0.0010.017-0.016

2. Books
2.3. Price to Book Ratio
  • Shows if the stock is under or overvalued compared to it's book value (total assets - total liabilities).
  • At or below 1 is considered healthy
  • A PB ratio of 3 means the investor is paying $3 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of RespireRx Pharmaceuticals Inc:

  • The EOD is -0.062. Bad. Book ratio is negative. -2
  • The MRQ is -0.040. Bad. Book ratio is negative. -2
  • The TTM is -0.116. Bad. Book ratio is negative. -2
Trends
Current periodCompared to+/- 
EOD-0.062MRQ-0.040-0.022
MRQ-0.040TTM-0.116+0.076
TTM-0.116YOY-0.230+0.113
TTM-0.1165Y-0.071-0.046
5Y-0.07110Y-0.035-0.035
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.0621.808-1.870
MRQ-0.0401.944-1.984
TTM-0.1162.750-2.866
YOY-0.2303.492-3.722
5Y-0.0712.731-2.802
10Y-0.0352.401-2.436

3. Summary

3.1. Key Performance Indicators

The key performance indicators of RespireRx Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share---0.095-0.103+8%-0.108+13%-1.062+1017%-0.531+458%
Current Ratio--0.0070.016-55%0.012-39%0.019-62%0.012-42%
Debt To Asset Ratio--144.24785.337+69%92.573+56%70.215+105%48.711+196%
Debt To Equity Ratio----0%-0%-0%1.629-100%
Eps---0.004-0.008+100%-0.020+382%-0.864+20956%-11.678+284556%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.600+67%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%2.754-100%
Pb Ratio-0.062-55%-0.040-0.116+191%-0.230+475%-0.071+77%-0.035-12%
Pe Ratio-0.180-55%-0.116-0.259+124%-0.223+93%-0.138+19%-0.078-32%
Peg Ratio--0.0020.003-40%0.002-14%0.002-6%0.001+260%
Price Per Share0.006+36%0.0040.012-69%0.022-83%0.381-99%0.533-99%
Quick Ratio----0%-0%-0%-0%
Return On Assets---6.181-5.323-14%-13.125+112%-7.076+14%-3.982-36%
Return On Equity----0%-0%-0%0.002-100%
 EOD+2 -1MRQTTM+4 -5YOY+5 -45Y+5 -410Y+8 -5

3.2. Fundamental Score

Let's check the fundamental score of RespireRx Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.180
Price to Book Ratio (EOD)Between0-1-0.062
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.007
Debt To Asset Ratio (MRQ)Less than1144.247
Debt to Equity Ratio (MRQ)Less than10.000
Return On Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-6.181
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of RespireRx Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.980
Ma 20Greater thanMa 500.007
Ma 50Greater thanMa 1000.006
Ma 100Greater thanMa 2000.006
OpenGreater thanClose0.006
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets78
Total Liabilities11,209
Total Stockholder Equity-11,131
 As reported
Total Liabilities 11,209
Total Stockholder Equity+ -11,131
Total Assets = 78

Assets

Total Assets78
Total Current Assets78
Long-term Assets78
Total Current Assets
Cash And Cash Equivalents 0
Total Current Assets  (as reported)78
Total Current Assets  (calculated)0
+/- 78
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities10,975
Long-term Liabilities234
Total Stockholder Equity-11,131
Total Current Liabilities
Short Long Term Debt 2,420
Accounts payable 5,265
Other Current Liabilities 321
Total Current Liabilities  (as reported)10,975
Total Current Liabilities  (calculated)8,006
+/- 2,969
Long-term Liabilities
Other Liabilities 234
Long-term Liabilities  (as reported)234
Long-term Liabilities  (calculated)234
+/-0
Total Stockholder Equity
Common Stock117
Total Stockholder Equity (as reported)-11,131
Total Stockholder Equity (calculated)117
+/- 11,249
Other
Capital Stock139
Common Stock Shares Outstanding 117,069
Net Debt 2,420
Net Invested Capital -8,733
Net Tangible Assets -11,153
Net Working Capital -10,897



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-31
> Total Assets 
1,141
3,488
3,445
6,828
6,022
5,540
6,069
4,415
3,872
2,981
2,480
1,400
1,092
2,179
5,845
6,528
23,538
22,891
26,278
23,302
20,858
17,989
19,941
16,281
13,402
10,435
11,854
9,517
21,486
18,429
15,233
11,656
8,094
5,152
2,871
1,930
1,847
706
8,550
5,608
4,880
3,567
2,101
1,773
678
1,821
952
679
3,691
199
135
54
33
52
441
312
166
400
395
226
514
146
137
578
201
234
411
191
184
195
164
143
204
124
145
150
107
45
100
86
56
85
106
142
230
209
103
78
78103209230142106855686100451071501451242041431641951841914112342015781371465142263954001663124415233541351993,6916799521,8216781,7732,1013,5674,8805,6088,5507061,8471,9302,8715,1528,09411,65615,23318,42921,4869,51711,85410,43513,40216,28119,94117,98920,85823,30226,27822,89123,5386,5285,8452,1791,0921,4002,4802,9813,8724,4156,0695,5406,0226,8283,4453,4881,141
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
196
379
163
161
177
150
132
197
121
145
150
107
45
100
86
56
85
106
142
230
209
103
78
781032092301421068556861004510715014512119713215017716116337919600000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,948
2,090
7,432
4,021
3,609
4,131
2,796
1,431
1,622
888
1,081
226
7,929
2,562
2,259
1,037
1,589
1,420
438
1,611
779
533
224
152
8
26
10
14
312
173
33
163
154
53
404
53
6
347
40
92
221
31
52
85
0
1
81
33
5
0
0
17
0
1
0
1
5
32
1
1
0
0
00113251010170053381108552312219240347653404531541633317331214102681522245337791,6114381,4201,5891,0372,2592,5627,9292261,0818881,6221,4312,7964,1313,6094,0217,4322,0902,94800000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,112
6,584
12,800
13,263
10,360
6,369
4,174
2,710
215
143
0
0
0
2,614
2,249
2,149
138
53
50
48
48
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000484850531382,1492,2492,6140001432152,7104,1746,36910,36013,26312,8006,5848,11200000000000000000000000000
   > Long-term Assets 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
426
399
379
426
516
497
491
473
472
451
414
377
340
299
277
249
271
269
451
472
454
439
451
441
448
428
420
431
826
851
921
901
861
809
757
709
664
383
314
310
276
250
225
198
101
67
56
48
46
0
0
0
0
0
2
2
13
17
17
16
14
12
10
9
7
5
3
2
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000012357910121416171713220000046485667101198225250276310314383664709757809861901921851826431420428448441451439454472451269271249277299340377414451472473491497516426379399426
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,381
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000003,381000000000000000000000000000000000000000000000000
> Total Liabilities 
791
1,135
1,816
5,819
5,221
5,420
4,706
3,852
4,095
3,573
3,683
2,796
2,538
3,599
2,162
2,676
1,804
2,402
2,402
2,025
2,053
2,857
2,350
2,497
2,266
2,115
1,648
1,729
2,086
1,752
2,509
2,536
1,866
1,755
2,485
2,143
1,893
2,234
4,142
1,793
1,535
1,164
1,240
1,239
1,324
1,145
1,193
1,753
2,810
3,191
3,964
4,063
4,139
4,240
2,897
2,516
2,314
2,600
3,003
2,804
2,614
3,008
3,921
4,273
5,047
5,727
6,323
6,500
6,950
4,550
5,141
5,212
5,563
5,857
6,373
6,767
7,146
7,490
7,552
7,932
7,344
8,148
8,560
8,959
9,655
10,216
10,971
11,209
11,20910,97110,2169,6558,9598,5608,1487,3447,9327,5527,4907,1466,7676,3735,8575,5635,2125,1414,5506,9506,5006,3235,7275,0474,2733,9213,0082,6142,8043,0032,6002,3142,5162,8974,2404,1394,0633,9643,1912,8101,7531,1931,1451,3241,2391,2401,1641,5351,7934,1422,2341,8932,1432,4851,7551,8662,5362,5091,7522,0861,7291,6482,1152,2662,4972,3502,8572,0532,0252,4022,4021,8042,6762,1623,5992,5382,7963,6833,5734,0953,8524,7065,4205,2215,8191,8161,135791
   > Total Current Liabilities 
791
1,135
1,816
5,819
2,411
3,027
2,729
2,292
2,952
2,846
3,373
2,055
2,044
3,352
2,162
2,299
1,426
2,021
2,370
1,927
1,985
2,807
2,296
2,439
2,208
2,056
1,590
1,686
2,046
1,727
2,498
2,536
1,866
1,755
2,485
2,141
1,887
2,223
2,794
1,774
1,516
1,156
1,237
1,239
1,324
1,145
1,193
1,753
2,810
3,191
3,964
4,063
4,139
4,240
2,897
2,516
2,314
2,600
3,003
2,804
2,614
3,008
3,921
4,273
5,047
5,727
6,323
6,500
6,950
4,550
5,141
5,212
5,563
5,857
6,373
6,767
7,146
7,490
7,552
7,932
7,344
8,148
8,560
8,959
9,323
9,922
10,707
10,975
10,97510,7079,9229,3238,9598,5608,1487,3447,9327,5527,4907,1466,7676,3735,8575,5635,2125,1414,5506,9506,5006,3235,7275,0474,2733,9213,0082,6142,8043,0032,6002,3142,5162,8974,2404,1394,0633,9643,1912,8101,7531,1931,1451,3241,2391,2371,1561,5161,7742,7942,2231,8872,1412,4851,7551,8662,5362,4981,7272,0461,6861,5902,0562,2082,4392,2962,8071,9851,9272,3702,0211,4262,2992,1623,3522,0442,0553,3732,8462,9522,2922,7293,0272,4115,8191,8161,135791
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,288
408
1,230
1,234
1,149
1,334
1,241
0
0
1,431
1,514
1,527
1,634
0
0
0
0
0
0
0
0
0
0
00000000001,6341,5271,5141,431001,2411,3341,1491,2341,2304081,28800000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,288
408
1,230
1,234
1,149
1,334
1,241
0
0
1,431
1,514
1,527
1,634
1,498
1,355
1,645
1,684
1,559
1,689
1,856
2,078
2,439
2,420
2,4202,4392,0781,8561,6891,5591,6841,6451,3551,4981,6341,5271,5141,431001,2411,3341,1491,2341,2304081,28800000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
511
470
531
331
256
392
613
179
339
226
779
488
548
852
696
1,456
658
1,306
966
1,154
1,157
1,852
1,110
1,390
1,330
1,413
945
1,021
1,429
971
1,703
1,856
1,234
1,123
1,838
1,521
1,268
1,575
2,031
1,128
1,516
394
479
568
608
473
522
812
1,305
1,510
1,704
1,769
1,787
1,830
1,891
1,467
1,635
1,846
2,173
1,464
1,410
1,434
1,769
1,942
2,264
2,494
2,705
2,792
2,958
2,922
2,798
2,829
2,889
2,678
3,442
2,653
2,968
3,070
3,235
3,408
3,748
4,064
4,746
4,818
4,737
4,528
5,158
5,265
5,2655,1584,5284,7374,8184,7464,0643,7483,4083,2353,0702,9682,6533,4422,6782,8892,8292,7982,9222,9582,7922,7052,4942,2641,9421,7691,4341,4101,4642,1731,8461,6351,4671,8911,8301,7871,7691,7041,5101,3058125224736085684793941,5161,1282,0311,5751,2681,5211,8381,1231,2341,8561,7039711,4291,0219451,4131,3301,3901,1101,8521,1571,1549661,3066581,456696852548488779226339179613392256331531470511
       Other Current Liabilities 
280
665
1,285
5,488
2,155
2,635
2,116
2,113
2,613
2,620
2,594
1,567
1,496
2,500
1,466
843
768
715
1,404
773
828
955
1,186
1,049
878
643
645
665
617
756
795
680
632
632
647
620
619
648
763
646
0
762
758
671
716
348
346
343
814
885
1,472
1,480
1,480
1,480
144
144
144
178
31
230
425
710
1,020
1,322
1,638
2,130
2,411
2,479
2,758
479
146
200
260
520
892
905
761
702
851
899
859
860
321
321
321
708
321
321
3213217083213213218608598998517027619058925202602001464792,7582,4792,4112,1301,6381,3221,020710425230311781441441441,4801,4801,4801,47288581434334634871667175876206467636486196206476326326807957566176656456438781,0491,1869558287731,4047157688431,4662,5001,4961,5672,5942,6202,6132,1132,1162,6352,1555,4881,285665280
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
332
294
264
234
234264294332000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
2,810
2,393
1,977
1,560
1,143
727
310
741
494
247
0
377
378
381
32
98
68
50
54
58
58
59
58
43
40
25
11
0
0
0
0
2
6
11
16
19
19
8
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
332
294
264
234
2342642943320000000000000000000000000000000000000000038191916116200001125404358595858545068983238137837702474947413107271,1431,5601,9772,3932,8100000
> Total Stockholder Equity
350
2,353
1,629
1,009
801
120
1,363
563
0
0
0
0
0
0
3,683
3,852
21,734
20,489
23,876
21,277
18,805
15,132
17,591
13,784
11,136
8,320
10,206
7,788
19,400
16,677
12,724
9,120
6,228
3,397
386
0
0
0
4,408
3,815
3,345
2,403
861
534
0
676
0
0
881
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-5,515
-5,911
-6,331
-6,788
-4,377
-4,999
-5,091
-5,381
-5,755
-6,228
-6,617
-7,039
-7,445
-7,451
-7,847
-7,288
-8,063
-8,455
-8,817
-9,425
-10,008
-10,868
-11,131
-11,131-10,868-10,008-9,425-8,817-8,455-8,063-7,288-7,847-7,451-7,445-7,039-6,617-6,228-5,755-5,381-5,091-4,999-4,377-6,788-6,331-5,911-5,51500000000000000008810067605348612,4033,3453,8154,4080003863,3976,2289,12012,72416,67719,4007,78810,2068,32011,13613,78417,59115,13218,80521,27723,87620,48921,7343,8523,6830000005631,3631208011,0091,6292,353350
   Common Stock
16
17
16
17
17
17
17
17
17
17
17
17
17
17
21
21
28
28
33
33
33
33
35
35
35
35
40
40
48
48
48
48
48
48
47
56
68
68
68
79
79
79
79
79
79
86
86
86
144
144
144
144
144
144
201
201
210
232
241
413
477
490
499
656
2
2
2
2
3
3
3
3
4
4
4
4
4
4
34
222
578
71
89
90
90
98
98
117
1179898909089715782223444444433332222656499490477413241232210201201144144144144144144868686797979797979686868564748484848484840403535353533333333282821211717171717171717171717161716
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.